688626 Xiangyu Medical
- 22.45
- -0.10-0.44%
Xiangyu Medical News
Xiangyu Healthcare (688626): 24H1 performance is under pressure and continues to increase R&D investment
Xiangyu Medical (688626): R&D and sales investment increased 2024H1 net profit under short-term pressure
Xiangyu Healthcare (688626): Industry-university-research innovation advantages highlight driving both revenue and profit growth
Guoxin Securities released a research report on April 25 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) rapid growth in performance in 2023, strong recovery in demand for rehabilitation d
Xiangyu Medical (688626): Net profit due to mother increased by 81% in 2023 and continued to increase R&D investment
Guohai Securities released a research report on April 23 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) achieving relatively rapid growth in performance; 2) focusing on shareholder return
Xiangyu Medical (688626): R&D builds competitive advantage, and performance achieves rapid growth
Open Source Securities released a research report on April 19 stating that it gave Xiangyu Healthcare (688626.SH) a purchase rating. The main reasons for the rating include: 1) rapid growth in 2023 performance, outstanding market advantages for a full ran
Xiangyu Healthcare (688626) 2023 Annual Report and 2024 Quarterly Report Review: Strong business recovery in 2023, equity incentives show confidence
Xiangyu Healthcare (688626): Steady growth in performance, optimistic about high-end layout
Xiangyu Medical (688626): Rehabilitation devices welcome a golden period of development, leading domestic producers set sail
Commentary on the 2023 Three-Quarter Report of Xiangyu Healthcare (688626): Strong performance recovery momentum, long-term optimism about rehabilitation demand
Xiangyu Medical (688626): Product upgrade+rapid increase in scale effect is sustainable
Xiangyu Healthcare (688626): Achieving rapid growth in revenue, equity incentives highlight confidence in growth
Xiangyu Medical (688626): Performance growth accelerates and the leading position in rehabilitation equipment is stable
XIANGYU MEDICAL(688626):ACCELERATED PERFORMANCE GROWTH LEADING POSITION OF REHABILITATION DEVICES CONSOLIDATED
Xiangyu Medical (688626) 2023 Interim Report Review: Strong Performance Recovery Momentum, Equity Incentives Show Confidence
Xiangyu Healthcare (688626) Interim Report: Demand for rehabilitation picked up after the pandemic
Xiangyu Medical (688626) Company Information Update Report: Rapid Growth in Performance and Strong Comprehensive Strength Entering the Fast Track of Development
Xiangyu Healthcare (688626) 2023 Semi-Annual Report Review: Strong Management Recovery, Equity Incentives Show Confidence
Analysis
Price Target
No Data
No Data